Kirk Tanner sees opportunities for the chocolate maker, as it navigates weight-loss drugs and stretched consumers.

While CEO Kirk Tanner didn't specify the connection, GLP-1 drug users have documented an unofficial side effect commonly ...

Hershey CEO Kirk Tanner says the company has seen an increase in demand for certain products.

Hershey says it's benefiting from the growing use of GLP-1 weight-loss drugs even as people cut down on snacks. Here's why.

Q1 2026 Management View CEO Kirk Tanner framed the competitive backdrop as stable on pricing while acknowledging earlier-than-expected activity in the aisle, saying, "competition continues to be ...

Hershey's gum and mint sales are rising as GLP-1 weight-loss drug users seek relief from side effects like 'Ozempic breath'.

Sales of Hershey's Ice Breakers rose 8% in the first quarter, thanks to the trend.

Hershey beat first-quarter earnings estimates, driven partly by an 8% jump in Ice Breakers gum and mint sales linked to rising GLP-1 drug use. CEO Kirk Tanner highlighted 'functional snacking' as a ...

Hershey reported an 8% rise in Ice Breakers gum and mint sales in the first quarter, partly driven by demand from users of GLP-1 weight-loss drugs like Ozempic and Wegovy. These medications can cause ...

Hershey reported an 8% quarterly sales increase for its Ice Breakers gum and mints, partly driven by demand from GLP-1 drug users experiencing bad breath. The trend highlights a surprising consumer ...